Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment resistant opioid use disorder (TROUD): Definition, rationale, and recommendations
David A. Patterson Silver Wolf, Mark S. Gold
Journal of the Neurological Sciences (2020) Vol. 411, pp. 116718-116718
Closed Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Carvone and its pharmacological activities: A systematic review
Lícia Tairiny Santos Pina, Mairim Russo Serafini, Marlange A. Oliveira, et al.
Phytochemistry (2022) Vol. 196, pp. 113080-113080
Closed Access | Times Cited: 51
Opioid use disorder: current trends and potential treatments
Yu Kyung Lee, Mark S. Gold, Kenneth Blum, et al.
Frontiers in Public Health (2024) Vol. 11
Open Access | Times Cited: 13
Evolution of an epidemic: Understanding the opioid epidemic in the United States and the impact of the COVID-19 pandemic on opioid-related mortality
R Laing, Christl A. Donnelly
PLoS ONE (2024) Vol. 19, Iss. 7, pp. e0306395-e0306395
Open Access | Times Cited: 5
Buprenorphine: New Challenges and Opportunities
Sabrina Corrêa da Costa, Mohammad Ghafouri, Lantie Jorandby, et al.
Current Addiction Reports (2025) Vol. 12, Iss. 1
Closed Access
Reliability of nociceptive monitors vs. standard practice during general anesthesia: a prospective observational study
Daniel Widarsson Norbeck, Sophie Lindgren, Axel Wolf, et al.
BMC Anesthesiology (2025) Vol. 25, Iss. 1
Open Access
Psychedelic Drugs in Mental Disorders: Current Clinical Scope and Deep Learning‐Based Advanced Perspectives
Sung‐Hyun Kim, Sumin Yang, Jeehye Jung, et al.
Advanced Science (2025)
Open Access
Statistical Validation of Risk Alleles in Genetic Addiction Risk Severity (GARS) Test: Early Identification of Risk for Alcohol Use Disorder (AUD) in 74,566 Case–Control Subjects
Kenneth Blum, David Han, Ashim Gupta, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 9, pp. 1385-1385
Open Access | Times Cited: 21
A Novel Precision Approach to Overcome the “Addiction Pandemic” by Incorporating Genetic Addiction Risk Severity (GARS) and Dopamine Homeostasis Restoration
Kenneth Blum, Shan Kazmi, Edward J. Modestino, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 3, pp. 212-212
Open Access | Times Cited: 24
Reward Deficiency Syndrome (RDS): A Cytoarchitectural Common Neurobiological Trait of All Addictions
Kenneth Blum, Abdalla Bowirrat, Eric R. Braverman, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 21, pp. 11529-11529
Open Access | Times Cited: 22
Machine Learning for Predicting Risk of Early Dropout in a Recovery Program for Opioid Use Disorder
Assaf Gottlieb, Andrea Yatsco, Christine Bakos‐Block, et al.
Healthcare (2022) Vol. 10, Iss. 2, pp. 223-223
Open Access | Times Cited: 14
How to Combat the Global Opioid Crisis.
Catherine Dennen A, Kenneth Blum, Eric Braverman R, et al.
PubMed (2023) Vol. 5, Iss. 4
Closed Access | Times Cited: 8
The Role of Physical Exercise in Opioid Substitution Therapy: Mechanisms of Sequential Effects
Alexandros Psarianos, Costas Chryssanthopοulos, Thomas Paparrigopoulos, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4763-4763
Open Access | Times Cited: 8
Nor-LAAM loaded PLGA microparticles for treating opioid use disorder
Diane Ingabire, Chaolong Qin, Tuo Meng, et al.
Journal of Controlled Release (2024) Vol. 373, pp. 93-104
Open Access | Times Cited: 2
A historical perspective on clonidine as an alpha-2A receptor agonist in the treatment of addictive behaviors: Focus on opioid dependence
Mark S. Gold, Kenneth Blum, Abdalla Bowirrat, et al.
INNOSC Theranostics and Pharmacological Sciences (2024) Vol. 7, Iss. 3, pp. 1918-1918
Closed Access | Times Cited: 2
Piloting Smart Home Sensors to Detect Overnight Respiratory and Withdrawal Symptoms in Adults Prescribed Opioids
Marian Wilson, Roschelle Fritz, Myles Finlay, et al.
Pain Management Nursing (2022) Vol. 24, Iss. 1, pp. 4-11
Open Access | Times Cited: 11
Looking beyond the opioid receptor: A desperate need for new treatments for opioid use disorder
Yu Kyung Lee, Mark S. Gold, Brian Fuehrlein
Journal of the Neurological Sciences (2021) Vol. 432, pp. 120094-120094
Closed Access | Times Cited: 15
Overcoming reward deficiency syndrome by the induction of “dopamine homeostasis” instead of opioids for addiction: illusion or reality?
Kenneth Blum, Diwanshu Soni, Rajendra D. Badgaiyan, et al.
Journal of Osteopathic Medicine (2022) Vol. 122, Iss. 7, pp. 333-337
Open Access | Times Cited: 9
Prevention, diagnosis, and treatment of opioid use disorder under the supervision of opioid stewardship programs: it's time to act now
Eunji Kim, Eun-Jung Hwang, Yeong Min Yoo, et al.
The Korean journal of pain (2022) Vol. 35, Iss. 4, pp. 361-382
Open Access | Times Cited: 9
Genetic Addiction Risk and Psychological Profiling Analyses for “Preaddiction” Severity Index
Kenneth Blum, David Han, Abdalla Bowirrat, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 11, pp. 1772-1772
Open Access | Times Cited: 9
A Source Control Model for Treatment-Resistant Substance Use Disorder
Matthew Robert Dernbach, Karen Drexler, Elizabeth F. McCord, et al.
Journal of Addiction Medicine (2024) Vol. 18, Iss. 5, pp. 483-485
Closed Access | Times Cited: 1
Reduced habenular volumes and neuron numbers in male heroin addicts: a post-mortem study
Ulf Müller, Moritz Ahrens, Veronika Vasilevska, et al.
European Archives of Psychiatry and Clinical Neuroscience (2020) Vol. 271, Iss. 5, pp. 835-845
Closed Access | Times Cited: 9
Adjunctive High-Definition Transcranial Direct Current Stimulation in Brain Glutamate-Glutamine and γ-Aminobutyric Acid, Withdrawal and Craving During Early Abstinence Among Patients With Opioid Use Disorder on Buprenorphine-Naloxone
Aravind Kumar, Sourav Khanra, Nishant Goyal, et al.
Journal of Ect (2022) Vol. 38, Iss. 2, pp. 124-132
Closed Access | Times Cited: 6
Long‐term recovery from opioid use disorder: recovery subgroups, transition states and their association with substance use, treatment and quality of life
William H. Craft, Hwasoo Shin, Allison N. Tegge, et al.
Addiction (2022) Vol. 118, Iss. 5, pp. 890-900
Open Access | Times Cited: 6
Resting State EEG Activity Related to Impulsivity in People with Prescription Opioid Use Disorder
Kim Corace, Renee Baysarowich, Melanie Willows, et al.
Psychiatry Research Neuroimaging (2022) Vol. 321, pp. 111447-111447
Closed Access | Times Cited: 5
Invited Expert Opinion- Bio-informatic and Limitation Di-rectives to Help Adopt Ge-netic Addiction Risk Screening and Identify Preaddictive Reward Dysregulation: Re-quired Analytic Evidence to Induce Dopamine Homeo-statsis
Kenneth Blum, Mark S. Gold, Jean Lud Cadet, et al.
Medical Research Archives (2023) Vol. 11, Iss. 8
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top